C
CGON
CG Oncology, Inc.
57.63
1.21+2.14%After Hours: 58.50 +0.87 +1.51%18:22 02/20 EST
OPEN/PREV CLOSE55.94/56.42
TODAY RANGE55.00-58.25
VOL730.17K
MARKET CAP4.65B
52 WEEK RANGE14.80-58.25
AVG VOL (3M)1.05M
% TURNOVER0.91%
TURNOVER--
P/E (TTM)-28.4298
% RANGE5.76%
EPS(TTM)-2.0271
P/E(FORWARD)-26.5576
P/B6.56
BVPS8.78
DIVIDEND--
P/S3,842.00
BETA--
DIV YIELD0.00%
FREE FLOAT MKT CAP4.25B
SHARES OUTSTANDING80.67M
NEXT EARNINGS03/26-03/30
FREE FLOAT73.81M
LOT SIZE1
EX-DATE--
News
Press Releases
Financial Reports
Profile
Simply Wall St·02/13 11:20
Did Faster PIVOT-006 Readout and Enlarged ATM Offering Just Shift CG Oncology's (CGON) Investment Narrative?
TipRanks·02/12 12:56
RBC Capital Sticks to Their Buy Rating for CG Oncology, Inc. (CGON)
TipRanks·02/10 14:20
CG Oncology price target raised to $75 from $66 at Truist
Benzinga·02/10 13:01
Expert Outlook: CG Oncology Through The Eyes Of 7 Analysts
Dow Jones·02/10 12:55
CG Oncology Price Target Raised to $75.00/Share From $66.00 by Truist Securities
Dow Jones·02/10 12:55
CG Oncology Is Maintained at Buy by Truist Securities
TipRanks·02/10 12:26
CG Oncology, Inc. (CGON) Gets a Buy from Truist Financial
TipRanks·02/04 13:03
Analysts’ Top Healthcare Picks: Cormedix (CRMD), CG Oncology, Inc. (CGON)
Simply Wall St·01/30 04:46
Is BOND-003’s Phase 3 Progress Reshaping The Investment Case For CG Oncology (CGON)?
Benzinga·01/21 18:00
What Analysts Are Saying About CG Oncology Stock
Dow Jones·01/21 14:55
CG Oncology Is Maintained at Outperform by RBC Capital
Same Industry
Name/Symbol
Change%
Price